
Sign up to save your podcasts
Or


At the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain, Dr. Henry Kuerer presented results from a study looking at whether some women diagnosed with early-stage triple-negative breast cancer or early-stage HER2-positive breast cancer could skip surgery if they had a pathologic complete response to chemotherapy before surgery.
Listen to the podcast to hear Dr. Kuerer explain:
By Breastcancer.org4.3
4242 ratings
At the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain, Dr. Henry Kuerer presented results from a study looking at whether some women diagnosed with early-stage triple-negative breast cancer or early-stage HER2-positive breast cancer could skip surgery if they had a pathologic complete response to chemotherapy before surgery.
Listen to the podcast to hear Dr. Kuerer explain:

22,041 Listeners

1,096 Listeners

2,041 Listeners

1,692 Listeners

2,629 Listeners

3,527 Listeners

9,255 Listeners

53 Listeners

4,379 Listeners

331 Listeners

377 Listeners

20,417 Listeners

1,185 Listeners

118 Listeners

30 Listeners